细胞内氧化还原环境 确定纳米集群的癌症正常细胞选择性
Zushuang Xiong1, Lizhen He1, Fen Pi1
1Department of Neurology and Stroke Center of The First Affiliated Hospital, College of Chemistry and Materials Science, Jinan University, Guangzhou, 510632, China.
Angewandte Chemie (International ed. in English)
|October 14, 2024
概括
工程纳米集群 (SeClus) 通过在氧化环境中代谢成细胞毒性化合物,选择性地向癌细胞,同时对正常细胞保持安全. 这一突破通过澄清氧化还原驱动的抗癌机制,推动了纳米医学的发展.
科学领域:
- 纳米医学是一种纳米医学.
- 材料科学 材料科学 材料科学
- 生物化学 生物化学
背景情况:
- 纳米药物的临床翻译受到理解化学结构和细胞内机制的限制.
- 细胞内氧化还原环境在细胞吸收后显著影响药物的疗效.
研究的目的:
- 为了工程 (Se) 纳米集群 (SeClus) 的结构响应细胞内氧化还原环境.
- 为了阐明由细胞氧化还原状态驱动的SeClus的抗癌机制.
主要方法:
- 原子工程的Se-Se/Se-S债券,以形成SeClus.
- 化学结构分析以确定SeClus形成驱动因素.
- 在体外研究评估SeClus转化和在正常与癌细胞中的疗效.
主要成果:
- 环的形成是由环中的硫原子结合所驱动的.
- 在正常细胞中,SeClus转化为单半氨酸,支持单蛋白合成.
- 在癌细胞中,氧化回氧环境将SeClus代谢为细胞毒性SeO3(2-),抑制了增殖.
结论:
- 基于细胞内氧化还原环境,SeClus表现出选择性的抗癌活性.
- 这项研究阐明了SeClus.的原子工程和氧化还原导向抗癌机制.
- 这些发现为开发更安全,更有效的纳米药物提供了有希望的战略.
相关概念视频
Electron Transport Chain: Complex I and II
12.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
12.1K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Selectins
3.3K
Cell adhesion is an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
3.3K


